Promotion	O
of	O
tumorigenesis	O
by	O
heterozygous	O
disruption	O
of	O
the	O
beclin	O
1	O
autophagy	O
gene	O
.	O

Malignant	B-Cell
cells	I-Cell
often	O
display	O
defects	O
in	O
autophagy	O
,	O
an	O
evolutionarily	O
conserved	O
pathway	O
for	O
degrading	O
long	O
-	O
lived	O
proteins	O
and	O
cytoplasmic	B-Cellular_component
organelles	I-Cellular_component
.	O

However	O
,	O
as	O
yet	O
,	O
there	O
is	O
no	O
genetic	O
evidence	O
for	O
a	O
role	O
of	O
autophagy	O
genes	O
in	O
tumor	B-Cancer
suppression	O
.	O

The	O
beclin	O
1	O
autophagy	O
gene	O
is	O
monoallelically	O
deleted	O
in	O
40	O
-	O
75	O
%	O
of	O
cases	O
of	O
human	O
sporadic	O
breast	B-Cancer
,	O
ovarian	B-Cancer
,	O
and	O
prostate	B-Cancer
cancer	I-Cancer
.	O

Therefore	O
,	O
we	O
used	O
a	O
targeted	O
mutant	O
mouse	O
model	O
to	O
test	O
the	O
hypothesis	O
that	O
monoallelic	O
deletion	O
of	O
beclin	O
1	O
promotes	O
tumorigenesis	O
.	O

Here	O
we	O
show	O
that	O
heterozygous	O
disruption	O
of	O
beclin	O
1	O
increases	O
the	O
frequency	O
of	O
spontaneous	O
malignancies	B-Cancer
and	O
accelerates	O
the	O
development	O
of	O
hepatitis	O
B	O
virus	O
-	O
induced	O
premalignant	B-Pathological_formation
lesions	I-Pathological_formation
.	O

Molecular	O
analyses	O
of	O
tumors	B-Cancer
in	O
beclin	O
1	O
heterozygous	O
mice	O
show	O
that	O
the	O
remaining	O
wild	O
-	O
type	O
allele	O
is	O
neither	O
mutated	O
nor	O
silenced	O
.	O

Furthermore	O
,	O
beclin	O
1	O
heterozygous	O
disruption	O
results	O
in	O
increased	O
cellular	B-Cell
proliferation	O
and	O
reduced	O
autophagy	O
in	O
vivo	O
.	O

These	O
findings	O
demonstrate	O
that	O
beclin	O
1	O
is	O
a	O
haplo	O
-	O
insufficient	O
tumor	B-Cancer
-	O
suppressor	O
gene	O
and	O
provide	O
genetic	O
evidence	O
that	O
autophagy	O
is	O
a	O
novel	O
mechanism	O
of	O
cell	B-Cell
-	O
growth	O
control	O
and	O
tumor	B-Cancer
suppression	O
.	O

Thus	O
,	O
mutation	O
of	O
beclin	O
1	O
or	O
other	O
autophagy	O
genes	O
may	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
human	O
cancers	B-Cancer
.	O

